|
- Ibrutinib: Uses, Dosage, Side Effects, Warnings - Drugs. com
Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, which is used to treat various blood cancers and also a serious complication of allogeneic stem cell transplants called chronic graft versus host disease (cGVHD)
- Ibrutinib - Wikipedia
Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that inhibits B-cell proliferation and survival by irreversibly binding the protein Bruton's tyrosine kinase (BTK)
- IMBRUVICA® (ibrutinib) | Official Patient Website
Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website See full Prescribing Safety Information
- Ibrutinib (oral route) - Side effects dosage - Mayo Clinic
Ibrutinib can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection It can also lower the number of platelets, which are necessary for proper blood clotting
- Ibrutinib (Imbruvica): Uses Side Effects - Cleveland Clinic
Ibrutinib is a medication that treats some types of cancer by slowing the growth of cancer cells It can also treat graft versus host disease
- Ibrutinib: Cancer Treatment Uses, Side Effects, Dosage
Ibrutinib is a novel targeted therapy for certain cancers of white blood cells in adults and is also used for the treatment of chronic graft versus host disease in adult and pediatric patients Ibrutinib is typically used to treat patients who have received at least one prior therapy
- Ibrutinib - NCI - National Cancer Institute
This page contains brief information about ibrutinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
- Ibrutinib: MedlinePlus Drug Information
Ibrutinib is used to treat adults with chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) and small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes)
|
|
|